165 related articles for article (PubMed ID: 27656837)
1. Suppression of Ubiquitin-Specific Peptidase 17 (USP17) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells.
Zhang S; Yuan J; Zheng R
Oncol Res; 2016; 24(4):263-9. PubMed ID: 27656837
[TBL] [Abstract][Full Text] [Related]
2. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis.
McFarlane C; McFarlane S; Paul I; Arthur K; Scheaff M; Kerr K; Stevenson M; Fennell DA; Johnston JA
Oncotarget; 2013 Oct; 4(10):1836-43. PubMed ID: 24123619
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells.
Chen W; Ni D; Zhang H; Li X; Jiang Y; Wu J; Gu Y; Gao M; Shi W; Song J; Shi W
Cancer Genet; 2023 Apr; 272-273():9-15. PubMed ID: 36640492
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non-small cell lung cancer.
Zhang S; Xu Z; Yuan J; Chen H
Oncol Lett; 2020 Jul; 20(1):67-74. PubMed ID: 32565935
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ubiquitin specific protease 17 restrains prostate cancer proliferation by regulation of epithelial-to-mesenchymal transition (EMT) via ROS production.
Baohai X; Shi F; Yongqi F
Biomed Pharmacother; 2019 Oct; 118():108946. PubMed ID: 31377470
[TBL] [Abstract][Full Text] [Related]
8. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
9. Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.
Tan X; Zhou F; Wan J; Hang J; Chen Z; Li B; Zhang C; Shao K; Jiang P; Shi S; Feng X; Lv N; Wang Z; Ling Y; Zhao X; Ding D; Sun J; Xiong M; He J
Cancer Biol Ther; 2010 Jan; 9(2):111-9. PubMed ID: 20009523
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells.
Shi J; Liu H; Yao F; Zhong C; Zhao H
Tumour Biol; 2014 Dec; 35(12):12005-13. PubMed ID: 25273169
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.
Qian Z; Zhao X; Jiang M; Jia W; Zhang C; Wang Y; Li B; Yue W
BMC Cancer; 2012 Oct; 12():442. PubMed ID: 23031673
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.
Tandon N; Goller K; Wang F; Soibam B; Gagea M; Jain AK; Schwartz RJ; Liu Y
EBioMedicine; 2019 Dec; 50():55-66. PubMed ID: 31761621
[TBL] [Abstract][Full Text] [Related]
13. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.
Li H; Lin PH; Gupta P; Li X; Zhao SL; Zhou X; Li Z; Wei S; Xu L; Han R; Lu J; Tan T; Yang DH; Chen ZS; Pawlik TM; Merritt RE; Ma J
Mol Cancer; 2021 Sep; 20(1):118. PubMed ID: 34521423
[TBL] [Abstract][Full Text] [Related]
14. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells.
Liu MH; Shi SM; Li K; Chen EQ
Oncol Res; 2016; 24(3):181-7. PubMed ID: 27458099
[TBL] [Abstract][Full Text] [Related]
16. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.
Hui L; Zhang S; Wudu M; Ren H; Xu Y; Zhang Q; Qiu X
Thorac Cancer; 2019 Jun; 10(6):1479-1488. PubMed ID: 31124298
[TBL] [Abstract][Full Text] [Related]
17. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA SLNCR1 regulates non‑small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2.
Xu W; Xu Q; Kuang D; Wang Z; Lu Q; Lin Q; Wu H; Chen L
Mol Med Rep; 2019 Sep; 20(3):2591-2596. PubMed ID: 31524254
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
